Therapeutics (TGTX) 2025 Earnings Outlook for Investors
TG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
Learn when mutual funds can be preferable to index funds, considering objectives, risk tolerance, and horizon. Make informed allocation decisions.
25,127 articlesTG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
Navan stock down from its IPO price has dropped sharply, but a major investor just built a substantial stake. Here’s ...
Dell Technologies posted a billion-dollar quarter, driven by AI server orders that surged in Q4 and propelled a raise...
The Supreme Court voided tariffs tied to IEEPA, triggering lawsuits and a complex path for refunds. Courts and agenci...
Oil prices jumped after fresh regional strikes disrupted Gulf supply routes, triggering a broader market rally in ene...
Nvidia unveils a $2 billion investment in Lumentum, pairing strategic scale with a fast-growing demand for AI-grade o...
A DTCC update effective March 2, 2026 unlocks post-trade routing of institutional volumes to the XRP Ledger, as Rippl...
United Airlines announced a new in-flight policy that could permanently bar passengers who refuse to wear headphones....
Cisco is betting on AI infrastructure and recurring revenue to escape dot-com era fears. With rising ARR, rising subs...
Pulmonx is navigating a pivotal year as it advances its lung care devices while contending with pacing competition an...
March brings renewed attention to sentinelone stock heading into a volatile market. This piece outlines why I’m watch...
As markets wobble in early 2026, utility ETFs provide a steady dividend stream and a shield against volatility. This ...